The island showcased its strengths as a top U.S. destination for reshoring, innovation, and advanced manufacturing, and announced the establishment of a new company in the island’s bioscience ecosystem.
Boston – Invest Puerto Rico (InvestPR), the island’s business attraction organization, led its largest-ever delegation to the BIO International Convention 2025 in Boston, the world’s premier biotechnology conference. The delegation—comprising more than 50 representatives from the public and private sectors, including leaders from Amgen, AbbVie, and CytoImmune— is scheduled to participate in over 100 meetings with companies exploring expansion or relocation to Puerto Rico.
As global supply chains face increasing volatility and trade barriers grow more complex, reshoring to U.S. jurisdictions has become a strategic imperative for the biosciences industry. At BIO International 2025, Invest Puerto Rico emphasized the island’s unique position as a tariff-free, cost-effective, and innovation-ready solution for companies looking to relocate or expand operations within U.S. borders. With no customs duties, seamless FDA compliance, and robust R&D capabilities, Puerto Rico offers a compelling alternative to traditional relocation destinations like Mexico and Canada.
“Our presence at BIO International 2025 focused on positioning Puerto Rico as a strategic gateway for bioscience innovation and investment,” said Ella Woger-Nieves, Chief Executive Officer of Invest Puerto Rico. “We’re proud to lead such a dynamic and collaborative delegation that reflects the strength of our ecosystem.”
Sebastián Negrón Reichard, Secretary of the Department of Economic Development and Commerce, noted, “BIO International is the perfect stage to showcase Puerto Rico’s strategic advantages in bioscience reshoring and innovation. In today’s shifting trade environment, the island offers greater stability and efficiency while boosting global competitiveness.”
Case in point: Ceria Therapeutics
Further underscoring the island’s momentum, Ceria Therapeutics (Ceria Tx)—a U.S.-based biopharmaceutical innovator whose CEO is joining the InvestPR delegation at BIO—will establish an R&D hub in Puerto Rico focused on RNA and nanoparticle manufacturing and analytics, conduct clinical trials locally, and offer U.S.-manufactured bespoke raw materials for global markets. The company expects to begin operations in 2026 at the Molecular Science Research Center (MSRC) in San Juan, generating close to 50 high-skilled jobs with an average annual salary of $100,000 and a $2.35 million capital investment over five years.
“Ceria Therapeutics’ arrival brings high-value job creation and adds critical capabilities to Puerto Rico’s biopharmaceutical landscape,” said Woger-Nieves. “It exemplifies how our ecosystem continues to attract cutting-edge players ready to grow, innovate, and lead.”
“Ceria’s planned R&D and clinical operations in San Juan highlight Puerto Rico’s growing role in driving U.S. supply-chain resilience and enhancing our advanced manufacturing capabilities,” added Secretary Negrón Reichard.
Puerto Rico continues to lead as a top bioscience manufacturing hub in the U.S., exporting over $53 billion in bioscience products annually, and producing eight of the world’s 15 top-selling pharmaceutical products. With more than 120 FDA-approved pharmaceutical and medical device sites on the island, a growing clinical research ecosystem, and world-class R&D infrastructure, the island offers a competitive environment for innovation. Businesses can also benefit from up to 50% in R&D tax credits, among the most attractive in the United States. These advantages make Puerto Rico a strategic location for bioscience investment, as well as a reliable partner for long-term growth in the global life sciences industry.
To learn more about Puerto Rico’s bioscience ecosystem, please visit www.investpr.org.
About Invest Puerto Rico
Invest Puerto Rico is a non-profit entity created by law to promote Puerto Rico as a competitive jurisdiction for investment, focused on attracting new businesses and capital. Our vision is to be a transformational and results-oriented accelerator of economic development for the island. For more information, visit www.investpr.org.
